Antonio Llombart-Cussac, MD
Arnau de Vilanova Hospital, Valencia (Spain)
3
3
0
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
José Pérez, MD
Institute of Breast Cancer, Quirón Group, Barcelona (Spain)
Shared therapeutic areas:
Worked with same sponsors:
Javier Cortés, MD, PhD
Institute of Breast Cancer, Quirón Group, Barcelona (Spain)
Shared therapeutic areas:
Worked with same sponsors:
José M Pérez-García, MD
International Breast Cancer Center (Spain)
Shared therapeutic areas:
Worked with same sponsors:
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Puma
Biotechnology
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
min yan
Henan Cancer Hospital
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
All 3 trials loaded